[HTML][HTML] Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects
H D'Avila, CNR Lima, PG Rampinelli… - International Journal of …, 2024 - mdpi.com
… 2 (SARS-CoV-2), and the disease it causes was termed coronavirus disease 19 (COVID-19)
[1]. It is now known that SARS-CoV-2 primarily spreads through respiratory droplets and …
[1]. It is now known that SARS-CoV-2 primarily spreads through respiratory droplets and …
[HTML][HTML] Lung fibrosis after COVID-19: treatment prospects
… post-COVID lung fibrosis and analyze the rationale for the current drug candidates. We discuss
the use of antifibrotic therapy for … of patients with COVID-associated pulmonary damage. …
the use of antifibrotic therapy for … of patients with COVID-associated pulmonary damage. …
COVID-19 and the heart
A Akhmerov, E Marbán - Circulation research, 2020 - Am Heart Assoc
… of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this
… The number of patients with the 2019 novel coronavirus disease (COVID-19) continues to …
… The number of patients with the 2019 novel coronavirus disease (COVID-19) continues to …
[HTML][HTML] Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease
… disorders, old age) and is a major cause of COVID-19-associated mortality (L. Tan, 2020)
[1]… 6 million COVID-19-related deaths have occurred as of January 2023 [2]. COVID-19 has …
[1]… 6 million COVID-19-related deaths have occurred as of January 2023 [2]. COVID-19 has …
[HTML][HTML] The find of COVID-19 vaccine: Challenges and opportunities
… COVID-19 in view of public health and vaccination discovery for the infectious SARS-CoV-2;
it is currently under-investigational therapeutic … measures to achieve" COVID-19/Flatten the …
it is currently under-investigational therapeutic … measures to achieve" COVID-19/Flatten the …
Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia
P Gentile, A Sterodimas - Expert opinion on biological therapy, 2020 - Taylor & Francis
… seven patients who suffered Coronavirus Disease 2019 (COVID-19) after an intravenous …
COVID-19 is a severe acute respiratory illness caused by a new coronavirus named severe …
COVID-19 is a severe acute respiratory illness caused by a new coronavirus named severe …
Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
… the coronavirus disease 2019 (COVID-19… coronavirus respiratory infection. There is a rapidly
increasing number of clinical investigations of cell-based therapy approaches for COVID-19…
increasing number of clinical investigations of cell-based therapy approaches for COVID-19…
[HTML][HTML] COVID-19 and thyroid: progress and prospects
… and comorbidities associated with coronavirus disease 2019 (COVID-19), those concerning
… The COVID-19 comorbidities and multi-consequences are central on a clinical and public …
… The COVID-19 comorbidities and multi-consequences are central on a clinical and public …
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
… reported as clinical manifestations of COVID-19 [18,19]. A study … big challenges for the
spreading of COVID-19 [20]. The close … for COVID-19, we here explore some potential therapeutic …
spreading of COVID-19 [20]. The close … for COVID-19, we here explore some potential therapeutic …
Therapeutic prospects of naturally occurring p38 MAPK inhibitors tanshinone IIA and pinocembrin for the treatment of SARS‐CoV‐2‐induced CNS complications
M Valipour - Phytotherapy Research, 2023 - Wiley Online Library
… activity/toxicity profiles for the treatment of COVID-19, tanshinone IIA and pinocembrin were
… after the emergence of COVID-19. By describing the association of COVID-19-induced CNS …
… after the emergence of COVID-19. By describing the association of COVID-19-induced CNS …